Graham Corporation (GHM) Q1 2027 earnings review
Top-Line Surges and Backlog Swells, But Investments Squeeze GAAP Profits
Graham Corporation's Q1 FY27 results showcase a massive divergence between top-line momentum and GAAP profitability. Revenue surged 29% to a record $71.3M, driven by intense Defense and Space demand, alongside inorganic growth from FlackTek. However, this growth did not flow to the bottom line—GAAP Net Income fell 15% and Operating Income dropped 16%. The culprit? A 150 bps gross margin contraction (driven by lower-margin defense material receipts) and a 33% spike in SG&A as the company invests heavily in its 'growth phase'. Despite the earnings drag, the balance sheet was radically transformed by a $50M strategic investment from T. Rowe Price, leaving GHM completely debt-free with a record $557.2M backlog.
🐂 Bull Case
The backlog hit a record $557.2M (+15% YoY), providing immense long-term visibility. A book-to-bill of 1.3x proves that order velocity remains robust even after previous mega-quarters.
The $50M T. Rowe Price capital injection allowed Graham to wipe out its $13M debt while boosting cash to $27M, fully funding its ambitious organic CapEx and future M&A strategy without leverage risk.
🐻 Bear Case
Operating margin deteriorated by 310 bps YoY to 5.8%. Until the $2.5M incremental SG&A investments and FlackTek integration costs scale, GAAP earnings will look ugly compared to revenue growth.
Energy & Process sales only grew 5%, salvaged largely by aftermarket and FlackTek. Core large capital projects are seeing 'push outs,' exposing vulnerability to macro CapEx cycles.
⚖️ Verdict: ⚪
Neutral. The underlying business is humming, and Adjusted EBITDA grew a healthy 28%. However, the heavy investments required to support this growth are currently penalizing GAAP margins. Until gross margins normalize away from material receipts, earnings growth will remain constrained.
Key Themes
Defense Growth Accelerating on Navy Program Execution
Defense remains the undisputed engine of Graham, with segment sales soaring 40% YoY to $41.4M. This growth is directly tied to the timing of project milestones and continued ramp-up on the U.S. Navy's Columbia and Virginia Class Submarine programs. Defense now constitutes 84% ($470.5M) of the total backlog, ensuring multi-year revenue stability.
Space Market Lift-Off
Space revenue is accelerating aggressively, up 86% YoY to $6.3M. Even more impressively, Space orders hit $14.4M in Q1 (a 2.3x book-to-bill ratio for the segment). Customers are actively transitioning from development to higher-rate production, validating the company's recent CapEx investments in cryogenic testing facilities.
SG&A Bloat Eating Operating Leverage
SG&A expenses surged 33% to $12.6M. Management attributed $1.8M to the FlackTek acquisition and $0.6M to integration costs. Crucially, the company is earmarking an additional $2.5M for the fiscal year to invest in 'people, processes, and technology.' While necessary for long-term scale, this is severely hampering near-term operating leverage, causing operating income to drop 16% despite a 29% revenue jump.
FlackTek Acquisition Proving Instantly Accretive to Top-Line
The FlackTek 'advanced mixing' platform (acquired Jan 2026) is executing well. In Q1, it contributed $6.6M to revenue and pulled in $13.2M in orders—a massive 2.0x book-to-bill ratio. This establishes FlackTek as a legitimate third core technology pillar capable of driving significant future growth.
Energy & Process Capital Project Push-Outs
Energy & Process revenue growth decelerated to a modest 5% YoY ($23.7M). Management explicitly noted that 'push outs on large capital project activity' dragged down the segment, which was only kept positive by strong aftermarket sales and FlackTek contributions. This signals macro hesitation among petrochemical and refining customers.
Gross Margin Compression from Sales Mix
Gross margin contracted by 150 bps YoY to 25.0%. As flagged in prior quarters, the defense business is seeing a higher proportion of 'material receipts'—which carry significantly lower margins before value-add labor is applied. While management views this as a timing issue, it acts as a persistent headwind on profitability.
Other KPIs
Accelerating. Backlog increased 15% YoY and 5% sequentially, marking the fifth consecutive quarter of record backlog. Driven heavily by Defense ($470.5M) and Space ($45.3M). Management expects 35-40% of this backlog to convert to revenue within the next 12 months.
Accelerating. Up 28% YoY from $6.8M. Adjusted EBITDA margin remained perfectly stable at 12.3%, masking the underlying GAAP deterioration by adding back the $1.2M in acquisition/integration costs, $1.1M in amortization, and $0.6M in equity-based compensation.
Reversing. A massive structural improvement. In Q1, GHM secured a $50M investment from T. Rowe Price. They used $13M to wipe out all outstanding debt, leaving a pristine balance sheet with $27M in cash and $74.5M in available revolver capacity to hunt for further M&A.
Guidance
Accelerating. Guidance was reaffirmed. The midpoint of $290M implies roughly 18% YoY growth over FY26's $245.3M. This is heavily supported by the company's projection that 35-40% of its $557M backlog will convert this year.
Accelerating. Guidance reaffirmed. The midpoint of $37.5M implies an aggressive 44% YoY growth compared to FY26's ~$26M. Given Q1 delivered $8.8M (23.5% of the annual midpoint), the company is currently on a normalized run-rate to achieve this, provided gross margins recover as guided.
Stable. Reaffirmed. Q1 came in at 25.0%, perfectly hitting the midpoint of this annual guidance despite the drag from defense material receipts.
Stable. Guidance includes $4M-$5M in equity comp, acquisition/ERP costs, plus $2.5M in incremental investments for 'people, processes, and technology.' Q1 SG&A was 17.6% of sales, indicating spending needs to moderate slightly or revenue needs to outpace it in the remaining quarters.
Key Questions
Energy & Process Project Delays
You noted 'push outs' on large capital project activity in the Energy & Process segment. What specific sub-sectors or regions are driving this hesitation, and do you expect these orders to return in FY27 or slip into FY28?
FlackTek Margin Profile
FlackTek contributed a massive 2.0x book-to-bill this quarter. However, in previous quarters, you noted FlackTek's EBITDA margin (~10%) was below the corporate average. How is the margin profile of these new FlackTek orders trending?
Capital Deployment from T. Rowe Price
After paying down the $13M in debt, you have significant dry powder from the $50M T. Rowe Price investment. Are you prioritizing further M&A to build a 'fourth pillar', or will these funds accelerate organic CapEx beyond the guided $18-$22M?